Key virus linked to lupus discovery revealed
A New Breakthrough in Understanding Lupus
A recent study has uncovered a potential link between a common childhood virus and lupus, an autoimmune disease that affects millions globally. The research highlights the Epstein-Barr virus (EBV) as a possible cause of the condition, offering new insights into its origins.
The findings were published in Science Translational Medicine and suggest that EBV, which is carried by over 90% of adults, could be responsible for triggering lupus in all cases. Dr. William Robinson, a professor of immunology and rheumatology at Stanford University and the study’s senior author, emphasized the significance of this discovery.
“This is the single most impactful finding to emerge from my lab in my entire career,” said Robinson. “We think it applies to 100 per cent of lupus cases.”
Understanding Lupus and Its Impact
Lupus is a complex autoimmune disease that causes the immune system to attack healthy tissues throughout the body. It can lead to inflammation affecting various organs such as the skin, joints, kidneys, heart, and nerves. Notably, the condition disproportionately impacts women, with approximately 90% of cases occurring in females.
While many individuals manage their symptoms with medication like ibuprofen, around 5% develop life-threatening complications. Currently, there is no known cure for lupus, making this new research particularly significant.
The Role of Epstein-Barr Virus
Epstein-Barr virus is best known for causing mononucleosis, often referred to as the "kissing disease." Most people contract it during childhood or adolescence through saliva, such as by sharing food or drinks or kissing. According to Robinson, the only way to avoid EBV is to live in a bubble, as the odds of contracting it are nearly 20 to 1 for those who have lived a normal life.
Once inside the body, EBV hides in B cells, which are responsible for producing antibodies to fight infections. However, the virus can manipulate these cells, turning some rogue and prompting others to attack the body's own tissues. This process appears to be what triggers lupus, according to the researchers.
Scientific Discoveries and Implications
Previously, scientists knew that nearly everyone with lupus carries EBV, but the exact connection remained unclear. The Stanford team used advanced sequencing technology to explore how the virus interacts with the immune system.
They found that in individuals with lupus, EBV-infected B cells are about 25 times more common than in healthy people. The virus produces a protein called EBNA2, which activates human genes that drive inflammation. These overactive B cells then trigger other immune cells to attack cell nuclei, a defining feature of lupus.
When enough of these rogue cells accumulate, a full-blown autoimmune response begins. Robinson and his team believe the same viral response could play a role in other autoimmune disorders, such as multiple sclerosis (MS), rheumatoid arthritis, and Crohn’s disease.
Potential for Future Treatments
The researchers noted that genetic factors, differences in viral strains, or other environmental triggers may explain why some individuals are more susceptible to autoimmune conditions like lupus. Several companies are already developing vaccines to prevent EBV infection, with some clinical trials underway. However, these vaccines would likely only protect people before exposure, meaning they would need to be administered early in life.
This groundbreaking research offers hope for new treatments and a deeper understanding of lupus and other autoimmune diseases. As scientists continue to explore the role of EBV, the potential for targeted therapies becomes increasingly promising.
